Nicotyl riboside compositions and methods of use
The invention relates to compositions of nicotinoyl ribosides and nicotinamide riboside derivatives and their methods of use. In some embodiments, the invention relates to methods of making nicotinoyl ribosides. In some embodiments, the invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinoyl riboside. In further embodiments, the invention relates to methods of using nicotinoyl ribosides and nicotinamide riboside derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival.
1. A compound having the formula:
and salt complexes thereof wherein R is selected from the group consisting of alkylamino, substituted alkylamino, dialkylamino, substituted dialkylamino, alkyloxy, substituted alkyloxy, aryloxy, substituted aryloxy, hydroxylamino, substituted hydroxylamino, O-alkyloxyamino, substituted O-alkyloxyamino, aminooxy, substituted aminoxy, N-alkylaminooxy, substituted N-alkylaminoxy, hydrazino, substituted hydrazino, alkylhydrazino, and substituted alkylhydrazino.
2. The compound of claim 1 , wherein said alkyloxy or substituted alkyloxy is —OMe, —OEt, or —OCH 2 CH 2 OH.
3. The compound of claim 1 , wherein said aryloxy is —OPh.
4. The compound of claim 1 , wherein said alkylamino or substituted alkylamino is —NHMe, —NHEt, —NHCH 2 CH 2 OH, —NHCH 2 CH═CH 2 , —NHCH(CH 3 ) 2 , —NHCH 2 CH 2 NH 2 , or —NHcyclopropyl.
5. The compound of claim 1 , wherein said dialkylamino is —N(CH 3 ) 2 or N substituted pyrrolidinyl.
6. A compound having the following formula:
and salt complexes thereof wherein,
R 1 is alkyloxy, substituted alkyloxy, aryloxy, substituted aryloxy, arylthio, substituted arylthio, alkylthio, substituted alkylthio, aminooxy, substituted aminoxy, N-alkylaminooxy, and substituted N-alkylaminooxy; and
R 2 , R 3 , and R 4 are the same or different and, at each occurrence, independently unsubstituted —C(═O)alkyl or substituted —C(═O)alkyl.
7. The compound of claim 6 , wherein said alkyloxy or substituted alkyloxy is —OMe, —OEt, or —OCH 2 CH 2 OH.
8. The compound of claim 6 , wherein said aryloxy is —OPh.
9. The compound of claim 6 , wherein R 2 , R 3 , and R 4 are acetyl.
10. A compound having the following formula:
and salt complexes thereof, wherein
R 1 is alkylamino, dialkylamino, substituted dialkylamino, hydrazine, substituted hydrazino, N-alkylaminohydrazino, hydroxylamino, substituted hydroxylamino, O-alkyloxyamino, substituted O-alkyloxyamino, —NHCH 2 CH 2 OH, —NHCH 2 CH═CH 2 , or —NHCH 2 CH 2 NH 2 ;
R 2 , R 3 , and R 4 are the same or different and, at each occurrence, independently unsubstituted —C(═O)alkyl or substituted —C(═O)alkyl.
11. The compound of claim 10 , wherein R 2 , R 3 , and R 4 are acetyl.
12. The compound of claim 10 , wherein R 1 is —NHMe, —NHEt, —NHCH 2 CH 2 OH, —NHCH 2 CH═CH 2 , —NHCH(CH 3 ) 2 , —NHCH 2 CH 2 NH 2 , or —NHcyclopropyl.
13. The compound of claim 10 , wherein R 1 is —N(CH 3 ) 2 or N substituted pyrrolidinyl.
14. A compound having the following formula:
and salt complexes thereof wherein
R 1 is alkylamino, substituted alkylamino, dialkylamino, substituted dialkylamino, hydroxylamino, O-alkyloxyamino, substituted O-alkyloxyamino, hydrazino, alkylhydrazino, or substituted alkylhydrazino, and
R 2 is unsubstituted —C(═O)alkyl, substituted —C(═O)alkyl, unsubstituted —C(═O)aryl, or substituted —C(═O)aryl.
15. The compound of claim 14 , wherein R 1 is selected from —NHMe, —NHEt, —NHCH 2 CH═CH 2 , and —NHCH 2 CH 2 NH 2 .
16. The compound of claim 15 , wherein R 2 is acetyl.
17. A pharmaceutical composition comprising a compound or salt complex thereof of claim 1 and a pharmaceutically acceptable carrier.
18. A pharmaceutical composition comprising a compound or salt complex thereof of claim 6 and a pharmaceutically acceptable carrier.
19. A pharmaceutical composition comprising a compound or salt complex thereof of claim 10 and a pharmaceutically acceptable carrier.
20. A pharmaceutical composition comprising a compound or salt complex thereof of claim 14 and a pharmaceutically acceptable carrier.
21. A compound having the following formula:
and salt complexes thereof wherein,
R 1 is substituted alkyloxy, aryloxy, substituted aryloxy, arylthio, substituted arylthio, alkylthio, substituted alkylthio, aminooxy, substituted aminoxy, N-alkylaminooxy, and substituted N-alkylaminooxy; and
R 2 , R 3 , and R 4 are the same or different and, at each occurrence, independently unsubstituted —C(═O)aryl or substituted —C(═O)aryl.
22. The compound of claim 21 , wherein said substituted alkyloxy is —OCH 2 CH 2 OH.
23. The compound of claim 21 , wherein said aryloxy is —OPh.
24. A compound having the following formula:
and salt complexes thereof, wherein
R 1 is alkylamino, substituted dialkylamino, hydrazine, substituted hydrazino, N-alkylaminohydrazino, hydroxylamino, substituted hydroxylamino, O-alkyloxyamino, substituted O-alkyloxyamino, —NHCH 2 CH 2 OH, —NHCH 2 CH═CH 2 , or —NHCH 2 CH 2 NH 2 ;
R 2 , R 3 , and R 4 are the same or different and, at each occurrence, independently unsubstituted —C(═O)aryl or substituted —C(═O)aryl.
25. The compound of claim 24 , wherein R 1 is —NHMe, —NHEt, —NHCH 2 CH 2 OH, —NHCH 2 CH═CH 2 , —NHCH(CH 3 ) 2 , —NHCH 2 CH 2 NH 2 , or —NHcyclopropyl.
26. The compound of claim 24 , wherein R 1 is N substituted pyrrolidinyl.
27. A compound having the following formula:
and salt complexes thereof, wherein
R 1 is amino and
R 2 is unsubstituted —C(═O)alkyl or substituted —C(═O)aryl.
28. A pharmaceutical composition comprising a compound or salt complex thereof of claim 21 and a pharmaceutically acceptable carrier.
29. A pharmaceutical composition comprising a compound or salt complex thereof of claim 24 and a pharmaceutically acceptable carrier.
30. A pharmaceutical composition comprising a compound or salt complex thereof of claim 27 and a pharmaceutically acceptable carrier.